Atlas Trials

This Was an Open-label, Single-arm Extension Study (CFTY720D2306E1) to a Double-blind, Randomized Multicenter, Placebo-controlled, Parallel-group Core Study (CFTY720D2306) in PPMS.

Clinical trial NCT00731692 · TERMINATED

Trial details

NCT number
NCT00731692
Sponsor
Novartis Pharmaceuticals
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Primary Progressive Multiple Sclerosis
Start date
2008-07-28
Primary completion
2015-06-22
Enrollment
970

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.